Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

Latest
70.84%
↓ 30% vs avg
Percentile
P67
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
101.41%
Historical baseline
PeriodValue
202570.84%
20241184.88%
20230.00%
20220.00%
2021100.00%
2020-645.83%
20190.00%